Nasopharyngeal Carcinoma

  • G. de Thé
  • J. H. C. Ho
  • C. S. Muir
Chapter

Abstract

Nasopharyngeal carcinoma (NPC) and Burkitt lymphoma (BL) are neoplasms for which there is strong evidence of a viral etiology. Their study exemplifies the problems inherent in chronic-disease epidemiology and in demonstrating a causal relationship between viruses and cancer in humans.(35,61,107)In humans, the geographical distribution of the main types of cancers is such that variations up to 100-fold exist for some sites, suggesting that the environment plays a critical role in their development.(50)If chemicals are generally believed to play the major role, environmental, physical, and microbiological agents should not be overlooked. Carcinogenesis is accepted by most epidemiologists to represent a multistep and multifactorial process,(159)the clinical onset of the tumor being only the last and obvious one.

Keywords

Fermentation Lymphoma Leukemia Malaria Myeloma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ali, M. Y., and Shanmugaratnam, K., Cytodiagnosis of nasopharyngeal carcinoma,Acta Cytol 11: 51 – 60 (1967).Google Scholar
  2. 2.
    Anderson, E. N., Jr., Anderson, M. L., and Ho, J. H. C., A study of the environmental backgrounds of young Chinese nasopharyngeal carcinoma patients, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 231–239, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  3. 3.
    Andersson-Anvret, M., Forsby, N., Klein, G., and Henle, W., Studies on the occurrence of Epstein—Barr virus DNA in nasopharyngeal carcinomas in comparison with tumors of other head and neck regions,Int. J. Cancer 20: 702 – 707 (1977).CrossRefGoogle Scholar
  4. 4.
    Andersson-Anvret, M., Forsby, N., Klein, G., and Henle, W., The association between undifferentiated nasopharyngeal carcinoma and Epstein—Barr virus shown by correlated nucleic acid hybridization and histopathological studies, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 347–358, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  5. 5.
    Andrews, P. A. I., and Michaels, I., Nasopharyngeal carcinoma in Canadian bush pilots, and aviator’s cancer,Lancet 2: 85, 640 (1968).Google Scholar
  6. 6.
    Armstrong, R. W., Armstrong, M. J., Yu, M. C., and Henderson, B. E., Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese,Cancer Res 43: 2967 – 2970 (1983).Google Scholar
  7. 7.
    Armstrong, R. W., Kannan-Kutty, M., and Armstrong, M. J., Self-specific environments associated with nasopharyngeal carcinoma in Selangor, Malaysia,Soc. Sci. Med. 12: 149 – 156 (1978).CrossRefGoogle Scholar
  8. 8.
    Aya, T., and Osato, T., Early events in transformation of human cord leukocytes by Epstein—Barr virus: Induction of DNA synthesis, mitosis and the virus associated nuclear antigen synthesis,Int. J. Cancer 14: 341 – 347 (1974).CrossRefGoogle Scholar
  9. 9.
    Bailar, J. C. III, Race, environment and family in the epidemiology of cancer of the nasopharynx, in:Cancer of the Nasopharynx, Vol. 1 (C. S. Muir and K. Shanmugaratnam, eds.), pp. 101 – 105, UICC Monograph Series, Munksgaard, Copenhagen, 1967.Google Scholar
  10. 10.
    Benyesh-Melnick, M., Fernbarch, D. J., and Lewis, R. T., Studies on human leukemia. I. Spontaneous lympho–blastoid transformation of fibroblastic bone marrow cultures derived from leukemic and non-leukemic children,J. Natl. Cancer Inst. 31: 1311 – 1331 (1963).Google Scholar
  11. 11.
    Betuel, H., Cammoun, M., Colombani, J., Day, N. E., Ellouz, R., and de-Thé, G., The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians,Int. J. Cancer 16: 249 – 254 (1975).CrossRefGoogle Scholar
  12. 12.
    Bjarnason, O., Day, N., Snaedal, G., and Tulinius, H., The effect of year on the breast cancer age incidence curve in Iceland,Int. J. Cancer 13: 689 – 696 (1974).CrossRefGoogle Scholar
  13. 13.
    Blot, W. J., Lanier, A., and Farumeni, J. F., Jr., Cancer mortality among Alaskan natives 1960–1969,J. Natl. Cancer Inst 55: 547 – 554 (1975).Google Scholar
  14. 14.
    Buell, P., Nasopharyngeal cancer in Chinese of California,Br. J. Cancer 19: 459 – 470 (1965).CrossRefGoogle Scholar
  15. 15.
    Buell, P., Race and place in the etiology of nasopharyngeal cancer: A study based on California death certificates,Int. J. Cancer 11: 268 – 272 (1973).CrossRefGoogle Scholar
  16. 16.
    Burkitt, D. P., The trail to a virus, in:Oncogenesis and Herpesviruses(P. M. Biggs, G. de-Thé, and L. N. Payne, eds.), pp. 345–348, IARC Scientific Publication No. 2, I ARC, Lyon, France, 1972.Google Scholar
  17. 17.
    Cammoun, M., Vogt-Hoerner, G., and Mourali, N., Les tumeurs du naso-pharynx en Tunisie: Étude anatomo-clinique de 143 observations,Tunis Med 49(3): 131 – 141 (1971).Google Scholar
  18. 18.
    Chan, S. H., Chew, T. S., Goh, E. H., Simons, M. J., and Shanmugaratnam, K., Impaired general cell-mediated immune functionsin vivoandin vitroin patients with nasopharyngeal carcinoma,Int. J. Cancer 18(2): 139 – 144, (1976).CrossRefGoogle Scholar
  19. 19.
    Churchill, A. E., Payne, L. N., and Chubb, R. C., Immunization against Marek’s disease using a live attenuated virus,Nature 221: 744 – 747 (1969).CrossRefGoogle Scholar
  20. 20.
    Clifford, P., Carcinoma of the nasopharynx in Kenya,East Afr. Med. J. 42: 373 – 396 (1965).Google Scholar
  21. 21.
    Clifford, P., Malignant diseases of the nasopharynx and paranasal sinuses in Kenya, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 82–94, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  22. 22.
    Clifford, P., A review on the epidemiology of nasopharyngeal carcinoma,Int. J. Cancer 5: 287 – 309 (1970).CrossRefGoogle Scholar
  23. 23.
    Clifford, P., Carcinogens in the nose and throat: Nasopharyngeal carcinoma in Kenya,Proc. R. Soc. Med. 65: 682 – 686 (1972).Google Scholar
  24. 24.
    Derry, D. E., Anatomical report (B), in:Archaeological Survey of Nubia(Bulletin No. 3), pp. 40 – 42, Egyptian Ministry of Finance, Cairo, 1909.Google Scholar
  25. 25.
    de Schryver, A., Friberg, S., Jr., Klein, G., Henle, W., Henle, G., de-Thé, G., Clifford, P., and Ho, H. C., Epstein—Barr associated antibody patterns in carcinoma of the post-nasal space,Clin Exp. Immunol. 5: 443 – 459 (1969).Google Scholar
  26. 26.
    de Schryver, A., Klein, G., Henle, G., Henle, W., Cameron, H., Santesson, L., and Clifford, P., Epstein—Barr virus associated serology in malignant disease: Antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens (EA) in patients with various neoplastic conditions,Int. J. Cancer 9: 353 – 364 (1972).CrossRefGoogle Scholar
  27. 27.
    Desgranges, C., and de-Thé, G., Presence of Epstein—Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: Their activity, origin, and possible clinical value, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 459–469, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  28. 28.
    Desgranges, C., de-Thé, G., Ho, J. H. C., and Ellouz, R., Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients,Int. J. Cancer 19: 627 – 633 (1977).CrossRefGoogle Scholar
  29. 29.
    Desgranges, C., Li, J. Y., and de-Thé, G., EBV specific secretory IgA in saliva of NPC patients: Presence of secretory piece in epithelial malignant cells,Int. J. Cancer 20: 881 – 886 (1977).CrossRefGoogle Scholar
  30. 30.
    Desgranges, C., Wolf, H., de-Thé, G., Shanmugaratnam, K., Ellouz, R., Cammoun, N., Klein, G., and zur Hausen, H., Nasopharyngeal carcinoma X—Presence of Epstein—Barr genomes in epithelial cells of tumours from high and medium risk areas,Int. J. Cancer 16: 7 – 15 (1975).CrossRefGoogle Scholar
  31. 31.
    de-Thé, G., Is Burkitt’s lymphoma (BL) related to a perinatal infection by Epstein—Barr virus?Lancet 1: 335 – 338 (1977).CrossRefGoogle Scholar
  32. 32.
    de-Thé, G., Epstein—Barr virus: Is it time to discuss a vaccine?Biomed. Comm. 28: 15 – 17 (1978).Google Scholar
  33. 33.
    de-Thé, G., The epidemiology of Burkitt’s lymphoma: Evidence for a causal association with Epstein—Barr virus—A review,Am. J. Epidemiol. 1: 32 – 57 (1979).Google Scholar
  34. 34.
    de-Thé, G., The role of the Epstein—Barr virus in human diseases: Infectious mononucleosis (IM), Burkitt’s lymphoma (BL), nasopharyngeal carcinoma (NPC), in:Viral Oncology(G. Klein, ed.), pp. 769 – 797, Raven Press, New York, 1979.Google Scholar
  35. 35.
    de-Thé, G., Multistep carcinogenesis, Epstein—Barr virus and human malignancies, in:Viruses in Naturally Occurring Cancers(M. Essex, G. Todaro, and H. zur Hausen, eds.), pp. 11–21, Cold Spring Harbor Conferences on Cell Proligeration, Vol. 7, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1980.Google Scholar
  36. 36.
    de-Thé, G., Ablashi, D. V., Liabeuf, A., and Mourali, N., Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies: Preliminary results,Biomedicine 19: 349 – 352 (1973).Google Scholar
  37. 37.
    de-Thé, G., Ambrosloni, J. C., Ho, H. C., and Kwan, H. C., Lymphoblastoid transformation and presence of herpes-types viral particles in a Chinese nasopharyngeal tumour culturedin vitro, Nature 221: 770 – 771 (1969).CrossRefGoogle Scholar
  38. 38.
    de-Thé, G., Day, N. E., Geser, A., Ho, J. H. C., Lavoue, M. F., Simons, M. J., Sohier, R., and Tukei, P., Epidemiology of the Epstein—Barr virus: Preliminary analysis of an international study, in:Oncogenesis and Herpesviruses II(G. de-Thé, M. A. Epstein, and H. zur Hausen, eds.), pp. 3–16, IARC Scientific Publication No. 11, Vol. 2,IARC, Lyon, France, 1975.Google Scholar
  39. 39.
    de-Thé, G., Desgranges, C., Zeng, Y., Wang, P. C., Bornkamm, G. W., Zhu, J. S., and Shang, M., Search for pre-cancerous lesions and EBV markers in the nasopharynx of IgA positive individuals, in:Nasopharyngeal Carcinoma, Vol. 5 (E. Grundmann, G. R. F. Krueger, and D. V. Ablash, eds.), pp. 111 – 117, Gustav Fisher Verlag, Stuttgart, 1981.Google Scholar
  40. 40.
    de-Thé, G., de-Vathaire, F., Sancho–Garnier, H., de-Thé, H., Schwaab, G., Micheau, C., Eschwege, F., Roche, N., Ellouz, R., and Ho, J. H. C., IgA/EA: Prognostic marker for relapse among NPC patients with complete remission after radiotherapy, in: Epstein—Barr Virus and Human Diseases (P. Levine, D. Ablashi, and G. Pearson, eds.), pp. 43 – 45, Humana Press, Clifton, N.J., 1987.Google Scholar
  41. 41.
    de-Thé, G., Geser, A., Day, N. E., Tukei, P. M., Williams, E. H., Beri, D. P., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, R., and Henle, W., Epidemiological evidence for causal relationship between Epstein—Barr virus and Burkitt’s lymphoma from Ugandan prospective study,Nature 274: 756 – 761 (1978).CrossRefGoogle Scholar
  42. 42.
    de-Thé, G., Ho, H. C., Kwan, H. C., Desgranges, C., and Favre, M. C., Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation,Int. J. Cancer 6: 189 – 206 (1970).CrossRefGoogle Scholar
  43. 43.
    de-Thé, G., Ho, J. H. C., Ablashi, D. V., Day, N. E., Macario, A. J. L., Martin-Berthelon, M. C., Pearson, G., and Sohier, R., Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV antigens in Chinese patients,Int. J. Cancer 16: 713 – 721 (1975).CrossRefGoogle Scholar
  44. 44.
    de-Thé, G., Lavoue, M.-F., and Muenz, L., Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 471–481, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  45. 45.
    de-Thé, G., Sohier, R., Ho, J. H. C., and Freund, R., Nasopharyngeal carcinoma. IV. Evolution of complement fixing antibodies during the course of the disease,Int. J. Cancer 12: 368 – 377 (1973).CrossRefGoogle Scholar
  46. 46.
    de-Thé, G., Vuillaumi, M., Giovanella, B. C., and Klein, G., Epithelial characteristics of tumour cells in nasopharyngeal carcinoma (NPC) passaged in nude mice—An ultrastructural study,J. Natl. Cancer Inst. 57: 1101 – 1105 (1976).Google Scholar
  47. 47.
    de-Thé, G., and Zeng, Y., Population screening for EBV markers toward improvement of nasopharyngeal carcinoma, in:The Epstein—Barr Virus Recent Advances(M. A. Epstein and B. G. Achong, eds.), pp. 236 – 249, William Heinemann Medical Books, London, 1986.Google Scholar
  48. 47a.
    de Vathaire, F., Sancho-Garnier, H., de Thé, H., Pieddeloup, C., Schwaab, G., Ho, J. H. C., Ellouz, R., Micheau, C., Cammoun, M., Cachin, Y., and de-Thé, G., Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma: A multicenter follow-up study,Int. J. Cancer,42: 176 – 181, 1988.CrossRefGoogle Scholar
  49. 48.
    Digby, K. H., Thomas, G. H., and Hsiu, S. T., Notes on carcinoma of the nasopharynx,Caduceus 9: 45 – 64 (1930).Google Scholar
  50. 49.
    Dobson, W. C., Cervical lymphosarcoma (letter to the editor),Chin. Med. J. 38: 786 (1924).Google Scholar
  51. 50.
    Doll, R., Epidemiology of cancer: Current perspectives,Am. J. Epidemiol. 104: 396 – 408 (1976).Google Scholar
  52. 51.
    Durand-Fardel, Cancer du pharynx—Ossification dans la substance musculaire du coeur,BullSoc. Anat. (Paris) 12: 73 – 80 (1837).Google Scholar
  53. 52.
    Epstein, M. A., and Achong, B. G., Recent progress in EB virus research,Annu. Rev. Microbiol(1977).Google Scholar
  54. 53.
    Epstein, M. A., Achong, B. G., and Barr, Y. M., Virus particles in cultured lymphoblasts from Burkitt’s lymphoma,Lancet 1: 702 – 703 (1964).CrossRefGoogle Scholar
  55. 54.
    Epstein, M. A., Morgan, A. J., Finerty, S., Randle, B. J., and Kirkwood, J. K., Protection of cottontop tamarins against EB virus-induced malignant lymphoma by a prototype subunit vaccine against MP gp 340, Nature 318:287–289 (1985).CrossRefGoogle Scholar
  56. 55.
    Evans, A. S., The history of infectious mononucleosis,Am. J. Med. Sci. 267: 189 (1974).CrossRefGoogle Scholar
  57. 56.
    Evans, A. S., New discoveries in infectious mononucleosis,Mod. Med. 1: 18 – 24 (1974).Google Scholar
  58. 57.
    Evans, A. S., and Niederman, J. C., Epidemiology of infectious mononucleosis, in:Oncogenesis and Herpesviruses(P. M. Biggs, G. de-Thé, and L. N. Payne, eds.), pp. 351–356, IARC Scientific Publications No. 2, IARC, Lyon, France, 1972.Google Scholar
  59. 58.
    Fong, Y. Y., and Chan, W. C., Bacterial production of dimethyl nitrosamine in salted fish,Nature 243: 421 – 422 (1973).CrossRefGoogle Scholar
  60. 59.
    Fong, Y. Y., and Walsh, E. O., Carcinogenic nitrosamines in Cantonese salt-dried fish,Lancet 1: 1032 (1971).CrossRefGoogle Scholar
  61. 60.
    Fraumeni, J. F., Jr., and Mason, T. J., Cancer mortality among Chinese Americans, 1950–69,J. Natl. Cancer Inst. 52: 659 – 665 (1974).Google Scholar
  62. 61.
    Gallo, R. C., Saxinger, W. C., Gallagher, R. E., Gillespie, D. A., Aulakh, G. S., and Wo Ng-Staal, F., Some ideas on the origin of leukemia in man and recent evidence for the presence of type-C viral related information, in:Origins of Human Cancer(H. Hiatt, J. D. Watson, and J. A. Winsten, eds.),Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4, Book B, pp. 1253 – 1285, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1977.Google Scholar
  63. 62.
    Gazzolo, L., de-Thé, G., and Vuillaume, M., Nasopharyngeal carcinoma. II. Ultrastructure of normal mucosa, tumor biopsies and subsequent epithelial growthin vitro, J. Natl. Cancer Inst 48: 73 – 86 (1972).Google Scholar
  64. 63.
    Gerber, P., and Birch, S., Complement-fixing antibodies in sera of human and non–human primates to viral antigens derived from Burkitt’s lymphoma cells,Proc. Natl. Acad. Sci. U.S.A. 58: 478 – 484 (1967).CrossRefGoogle Scholar
  65. 64.
    Gerber, P., Nonoyama, M., Lucas, S., Perlin, E., and Goldstein, L., Oral excretion of EBV by healthy subjects and patients with infectious mononucleosis,Lancet 2: 988 – 989 (1972).CrossRefGoogle Scholar
  66. 65.
    Gerber, P., Whang-Peng, J., and Monroe, J., Transformation and chromosome changes induced by Epstein—Barr virus in normal human leukocyte cultures,Proc. Natl. Acad. Sci. U.S.A. 63: 740 – 747 (1969).CrossRefGoogle Scholar
  67. 66.
    Geser, A., Charnay, N., Day, N. E., de-Thé, G., and Ho, H. C., Environmental factors in the etiology and nasopharyngeal carcinoma: Report on a case-control study in Hong Kong, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 213–229, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  68. 67.
    Geser, A., Day, N. E., de-Thé, G., Chew, T. S., Freund, R. J., Kwan, H. C., Lavoue, M. F., Simkovic, D., and Sohier, R., The variability in immunofluorescent viral capsid antigen antibody testing in population surveys of Epstein—Barr virus infection,Bull WHO 50: 389 – 400 (1974).Google Scholar
  69. 68.
    Glaser, R., de-Thé, G., Lenoir, G., and Ho, J. H. C., Superinfection of nasopharyngeal carcinoma epithelial tumour cells with Epstein—Barr virus,Proc. Natl. Acad. Sci. U.S.A. 73: 960 – 963 (1976).CrossRefGoogle Scholar
  70. 69.
    Goldenberg, G. J., Brandes, L. J., Lau, W. H., Miller, A. B., Wall, C., and Ho, J. H. C., Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein—Barr virus antibody activity,Cancer Treat. Rep. 69: 761 – 767 (1985).Google Scholar
  71. 70.
    Green, M. H., Fraumeni, J. F., Jr., and Hoover, R., Nasopharyngeal cancer among youngs in United States: Racial variations by cell type,J. Natl. Cancer Inst. 58: 1267 – 1270 (1977).Google Scholar
  72. 71.
    Hawkins, B. R., Simons, M. J., Goh, E. H., Chia, K. B., and Shanmugaratnam, K. Immunogenetic aspects of nasopharyngeal carcinoma. II. Analysis of ABO, Rhesus and MNS’s red cell systems,Int. J. Cancer 13: 116 – 121 (1974).CrossRefGoogle Scholar
  73. 72.
    Henderson, B. E., and Louie, E., Discussion of risk factors for nasopharyngeal carcinoma, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 251–260, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  74. 73.
    Henderson, B. E., Louie, E., Jing, J. S. H., Buell, P., and Gardner, M. B., Risk factors associated with nasopharyngeal carcinoma,N. Engl. J. Med. 295: 1101 – 1106 (1976).CrossRefGoogle Scholar
  75. 74.
    Henle, G., Antibodies to EBV-induced early antigens in infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal carcinoma, in:Recent Advances in Human Tumor Virology and Immunology(W. Nakahara, K. Nishoka, T. Hirayama, and T. Ito, eds.), pp. 343–359, University of Tokyo, 1971.Google Scholar
  76. 75.
    Henle, G., and Henle, W., Immunofluorescence in cells derived from Burkitt’s lymphoma,J. Bacteriol. 91: 1248 – 1256 (1966).Google Scholar
  77. 76.
    Henle, G., and Henle, W.. Epstein—Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma,Int. J. Cancer 17: 1 – 7 (1976).CrossRefGoogle Scholar
  78. 77.
    Henle, G., Henle, W., and Klein, G., Demonstration of two distinct components in the early antigen complex of EBV infected cells,Int. J. Cancer 8: 272 – 282 (1971).CrossRefGoogle Scholar
  79. 78.
    Henle, W., and Henle, G., Epstein—Barr virus: The cause of infectious mononucleosis, in:Oncogenesis and Herpesviruse s(P. M. Biggs, G. de-Thé, and L. N. Payne, eds.), pp. 358–370, IARC Scientific Publication No. 2, IARC, Lyon, France, 1972.Google Scholar
  80. 79.
    Henle, W., and Henle, G., Epstein—Barr virus and infectious mononucleosis,N. Engl. J. Med. 288: 263 – 264 (1978).CrossRefGoogle Scholar
  81. 80.
    Henle, W., Henle, G., Burtin, P., Cachin, Y., Clifford, P., de Schryver, A., de-Thé, G., Diehl, V., Ho, H. C., and Klein, G., Antibodies to Epstein—Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups,J. Natl. Cancer Inst. 44: 225 – 231 (1970).Google Scholar
  82. 81.
    Henle, W., Henle, G., Zajac, B. A., Pearson, G., Waubke, R., and Scriba, M., Differential reactivity of human serums with early antigens induced by Epstein—Barr virus,Science 169: 188 – 190 (1970).CrossRefGoogle Scholar
  83. 82.
    Henle, W., Ho, H. C., and Kwan, H. C., Antibodies to Epstein—Barr virus related antigens in nasopharyngeal carcinoma: Comparison of active cases with long term survivors,J. Natl. Cancer Inst. 51: 361 – 369 (1973).Google Scholar
  84. 83.
    Higginson, J., de-Thé, G., Geser, A., and Day, N. E., An epidemiological analysis of cancer vaccines,Int. J. Cancer 7: 565 – 574 (1971).CrossRefGoogle Scholar
  85. 84.
    Higginson, J., and MacLennan, R., The world pattern of cancer incidence, in:Modern Trends in Oncology—Research Progress(R. W. Raven, ed.), pp. 9 – 27, Butterworths, London, 1973.Google Scholar
  86. 85.
    Ho, H. C., Nasopharyngeal carcinoma in Hong Kong, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 58–63, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  87. 86.
    Ho, H. C., Incidence of nasopharyngeal cancer in Hong Kong, UICC Bulletin,Cancer 9(2): 5 (1971).Google Scholar
  88. 87.
    Ho, H. C., Radiologic diagnosis of nasopharyngeal carcinoma with special reference to its spread through the base of skull, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 238–246, UICC Monograph Series, Vol. 1, Medical Examination Publishing Co., New York, 1972.Google Scholar
  89. 88.
    Ho, H. C., Head and neck—Radiologic diagnosis,J.A.M.A. 220: 396 (1972).CrossRefGoogle Scholar
  90. 89.
    Ho, H. C., Current knowledge of the epidemiology of nasopharyngeal carcinoma—A review, in:Oncogenesis and Herpesviruses(P. M. Biggs, G. de-Thé, and L. N. Payne, eds.), pp. 357–366, IARC Scientific Publication No. 2, IARC, Lyon, France, 1972.Google Scholar
  91. 90.
    Ho, H. C., Epidemiology of nasopharyngeal carcinoma (NPC), in:Proceedings of the 1st Asian Cancer Conference, pp. 357 – 366 Shima Publ., Tokyo, 1973.Google Scholar
  92. 91.
    Ho, H. C., Epidemiology of nasopharyngeal carcinoma,J. R. Coll Surg. (Edinburgh) 20: 223 – 235 (1975).Google Scholar
  93. 92.
    Ho, H. C., Kwan, H. C., and Ng, M. H., Immunohisto-chemistry of local immunoglobulin production in nasopharyngeal carcinoma,Br. J. Cancer 37: 514 – 519 (1978).CrossRefGoogle Scholar
  94. 93.
    Ho, H. C., Kwan, H. C., Ng, M. H., and de-Thé, G., Serum IgA antibodies to Epstein—Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma,Lancet 1: 436 – 437 (1978).CrossRefGoogle Scholar
  95. 94.
    Ho, H. C., Ng, M. H., and Kwan, H. C., IgA antibodies to Epstein—Barr virus viral capsid antigens in saliva of nasopharyngeal carcinoma patients,Br. J. Cancer 35: 888 – 890 (1977).CrossRefGoogle Scholar
  96. 95.
    Ho, J. H. C., The natural history and treatment of nasopharyngeal carcinoma (NPC), in:Oncology, Vol. 4,Proceedings of the 10th International Cancer Congress(R. Lee-Clark, R. W. Cumley, J. E. McCay, and M. Copeland, eds.), pp. 1 – 14, Year Book Medical Publishers, Chicago, 1970.Google Scholar
  97. 96.
    Ho, J. H. C., Genetic and environmental factors in nasopharyngeal carcinoma, in:Recent Advances in Human Tumor Virology and Immunology, Proceedings of the First International Cancer Symposium of the Princess Takamatsu Cancer Research Fund(W. Nakahara, K. Nishioka, T. Hirayama, and Y. Ito, eds,), pp. 275 – 295, University of Tokyo Press, Tokyo, 1971.Google Scholar
  98. 97.
    Ho, J. H. C., Nasopharyngeal carcinoma (NPC), in:Advances in Cancer Research(G. Klein, S. Weinhouse, and A. Haddow, eds.), pp. 57 – 92, Academic Press, New York and London, 1972.CrossRefGoogle Scholar
  99. 98.
    Ho, J. H. C., An epidemiologic and clinical study of nasopharyngeal carcinoma,Int. J. Radiat. Oncol. Biol. Phys. 4: 181 – 198 (1978).Google Scholar
  100. Ho, J. H. C., Cancer in Hong Kong: Some epidemiological observations, in:Third Symposium on Epidemiology and Cancer Registries in the Pacific Basin held in Maui, Hawaii, January 19–23,1981, pp. 37–54, NCI Monograph 62, NIH, Bethesda, MD, 1982.Google Scholar
  101. 100.
    Ho, J. H. C., Huang, D. P., and Fong, Y. Y., Salted fish and nasopharyngeal carcinoma in southern Chinese,Lancet 1: 626 (1978).CrossRefGoogle Scholar
  102. 101.
    Ho, J. H. C., Ng, M. H., Kwan, H. C., and Chan, J. C. W., Epstein—Barr virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma,Br. J. Cancer 34: 655 – 660 (1976).CrossRefGoogle Scholar
  103. 102.
    Hu, C. H., and Yang, C., A decade of progress in morphologic pathology,Chin. Med. J. 79: 409 – 422 (1959).Google Scholar
  104. 103.
    Huang, D. P., Gough, T., and Ho, J. H. C., Analysis for volatile nitrosamines of salt–preserved foodstuffs traditionally consumed by southern Chinese, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 309–314, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  105. 104.
    Huang, D. P., Ho, J. H. C., Henle, W., and Henle, G., Demonstration of Epstein—Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies,Int. J. Cancer 14: 580 – 588 (1974).CrossRefGoogle Scholar
  106. 105.
    Huang, D. P., Saw, D., Teoh, T. B., and Ho, J. H. C., Carcinomas in rats fed with Cantonese salted marine fish, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 315–328, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  107. 106.
    Hubert, A., and de-Thé, G., Comportement alimentaire, Modes de vie et cancer du rhinopharynx (NPC),Bull. Cancer (Paris) 69(5): 476 – 482 (1982).Google Scholar
  108. 107.
    Huebner, R. J., and Todaro, G. T., Oncogenesis of RNA tumor viruses as determinants of cancer,Proc. Natl. Acad. Sci. U.S.A. 64:1087–1094 (1969).CrossRefGoogle Scholar
  109. 108.
    International Agency for Research on Cancer (IARC),Cancer Incidence in Five Continents, VolIII (J. Waterhouse, C. S. Muir, P. Correa, and G. Powell, eds.), IARC Scientific Publication No. 15, IARC, Lyon, France, 1976.Google Scholar
  110. 109.
    International Agency for Research On Cancer (IARC),Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  111. 110.
    International Agency for Research on Cancer (IARC), Annual Report, pp. 75–76, IARC, Lyon, France, 1978.Google Scholar
  112. 111.
    International Union Against Cancer [Union International Contre le Cancer (UICC)],Cancer of the Nasopharynx, Monograph Series, Vol. 1 ( C. S. Muir and K. Shanmugaratnam, eds.), Munksgaard, Copenhagen, 1967.Google Scholar
  113. 112.
    Jondal, M., and Klein, G., Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies,Biomedicine 23: 163 – 165 (1975).Google Scholar
  114. 113.
    Jung, P. F., and Yu, C.. Nasopharyngeal cancer in China,Postgrad. Med. 33: A77 – A82 (1963).Google Scholar
  115. 114.
    King, H., and Haenszel, K.. Cancer mortality among foreign and native-born Chinese in the United States,J. Chron. Dis. 26: 623 – 646 (1972).CrossRefGoogle Scholar
  116. 115.
    Kirk, R. L., Blake, N. M., Serjeantson, S., Simons, M. J., and Chan, S. H., Genetic components in susceptibility to nasopharyngeal carcinoma, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 283— 297, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  117. 116.
    Klein, G., EBV associated membrane antigens, in:Oncogenesis and Herpesviruses(P. M. Biggs, G. de-Thé, and L. N. Payne, eds.), pp. 295–301, IARC Scientific Publication No. 2, IARC, Lyon, France, 1972.Google Scholar
  118. 117.
    Klein, G., The Epstein—Barr virus, in:The Herpesviruses(A. Kaplan, ed.), pp. 521 – 555, Academic Press, New York, 1973.Google Scholar
  119. 118.
    Klein, G.,Viral Oncology, Raven Press, New York, 1979.Google Scholar
  120. 119.
    Klein, G., Clifford, P., Klein, E., and Stjernsward, J., Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction,Proc. Natl. Acad. Sci. U.S.A. 55: 1628 – 1635 (1966).CrossRefGoogle Scholar
  121. 120.
    Klein, G., Giovanella, B. C., Lindahl, T., Fialkow, P. J., Singh, S., and Stehlin, J., Direct evidence for the presence of Epstein—Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic carcinoma of the nasopharynx,Proc. Natl. Acad. Sci. U.S.A. 71: 4737 – 4741 (1974).CrossRefGoogle Scholar
  122. 121.
    Klein, G., Pearson, G., Henle, G., Henle, W., Diehl, V., and Niederman, J. C., Relation between Epstein—Barr viral and cell membrane immunofluorescence in Burkitt tumour cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus,J. Exp. Med. 128: 1011 – 1020 (1968).CrossRefGoogle Scholar
  123. 122.
    Klein, G., and Vonka, V., Relationship between the Epstein—Barr virus (EBV) determined, complement fixing antigen and the nuclear antigen (EBNA) detected by anti-complement fluorescence,Int. J. Cancer 53: 1645 – 1646 (1974).Google Scholar
  124. 123.
    Kmet, J., and Mahboubi, E., Esophageal cancer in the Gaspian littoral of Iran: Initial studies,Science 175: 846 – 853 (1972).CrossRefGoogle Scholar
  125. 124.
    Krogman, W. M., The skeletal and dental pathology of an early Iranian site,Bull. Hist. Med. 8: 28 – 48 (1940).Google Scholar
  126. 125.
    Laufs, R., Immunisation of marmoset monkeys with a killed oncogenic herpesvirus,Nature 249: 571 – 572 (1974).CrossRefGoogle Scholar
  127. 126.
    Lemaigre, G., Diebold, J., Temmim, L., Arseniev, L., Lecharpentier, Y., Allouache, A., Delaitre, B., and Abelanet, R., Carcinome du nasopharynx chez les sujets jeunes—Etude clinique, anatomique et ultrastructurale de 50 cas observes dans Test algerien,Nouv. Press Med. 6: 3509 – 3513 (1977).Google Scholar
  128. 127.
    Lemon, S. M., Hutt, L. M., Shaw, J., Li, J. L., and Pagano, J., Replication of EBV in epithelial cells during infectious mononucleosis,Nature 268: 268 – 270 (1977).CrossRefGoogle Scholar
  129. 128.
    Lenoir, G., Martin-Berthelon, M. C., Favre, M. C., and de-Thé, G., Characterization of EBV antigens. I. Biochemical analysis of the complement–fixing soluble antigen and relationship with EBNA,J. Virol. 17: 672 – 674 (1976).Google Scholar
  130. 129.
    Levine, P., Cho, B., Connelly, R., de Vita, C., Berard, C., O’Conor, G., and Dorhman, R., The American Burkitt’s lymphoma registry: A progress report,Ann. Intern. Med. 83: 82 – 83 (1975).Google Scholar
  131. 130.
    Levine, P. H., de-Thé, G., Brugere, J., Schwaab, G., Mourali, N., Heberman. R. B., Ambrosioni, J. C., and Revol, P., Immunity to antigens associated with a cell line derived from nasopharyngeal carcinoma (NPC) in non–Chinese NPC patients,Int. J. Cancer 17: 155 – 160 (1976).Google Scholar
  132. 131.
    Liang, P. C., Studies on nasopharyngeal carcinoma in the Chinese: Statistical and laboratory investigation,Chin. Med. J. 83: 373 – 390 (1964).Google Scholar
  133. 132.
    Lilly, F., The inheritance of susceptibility of the Gross leukemia virus in mice,Genetics 53: 529 – 539 (1966).Google Scholar
  134. 133.
    Lilly, F., Mouse leukemia: A model of a multiple-gene disease,J. Natl. Cancer Inst. 49: 927 – 934 (1972).Google Scholar
  135. 134.
    Lin, T. M., Chen, K. P., Lin, C. C., Hsu, M. M., Tu, S. M., Chiang, T. C., Jung, P. F., and Hirayama, T., Retrospective study on nasopharyngeal carcinoma,J. Natl. Cancer Inst. 51: 1403 – 1408 (1975).Google Scholar
  136. 135.
    Lin, T. M., Hsu, M. M., Cheng, K. P., Chiang, T. C., Jung, P. F., and Hirayama, T., Morbidity and mortality of cancer of the nasopharynx in Taiwan,Gann Monogr 10: 137 – 144 (1972).Google Scholar
  137. 136.
    Linsell, C. A., Cancer in Kenya, in:Cancer in Africa(P. Clifford, C. A. Linsell, and G. L. Timms, eds.), pp. 7 – 12, East African Publishing House, Nairobi, 1968.Google Scholar
  138. 137.
    Lu, S. J., Degos, L., Lepage, V., Huang, P. H., Chan, S. H., Simons, M., Macknight, B., Easton, D., Zeng, Y., de-Th– G., and Day, N. E., The Genetic Basis for Carcinoma of the Nasopharynx (NPC): Evidence of Linkage to Genes in the HLA region Among South Chinese, submitted for publication.Google Scholar
  139. 138.
    Mathew, G. D., Qualtiere, L. F., Neel, H. B. III, and Pearson, G. R., IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma,Int. J. Cancer 27: 175 – 180 (1981).CrossRefGoogle Scholar
  140. 139.
    McDevitt, H. O., and Bodmer, W. J., HL-A, immune response genes, and disease: Occasional survey,Lancet 1: 1269 – 1275 (1974).CrossRefGoogle Scholar
  141. 140.
    Michaux, L., Carcinome de base du crane, Cited by Godtfredson, E., Ophthalmologic and neurologic symptoms of malignant nasopharyngeal tumours: Clinical study comprising 454 cases, with special reference to histo-pathology and possibility of earlier recognition,Acta Psychiatr. Scand. [Suppl.] 34: 1 – 323 (1944).Google Scholar
  142. 141.
    Miller, G.. Niederman, J. C., and Still, D. A., Infectious mononucleosis: Appearance of neutralizing antibody to Epstein—Barr virus measured by inhibition of formation of lymphoblastoid cell lines,J. Infect. Dis. 125: 403 – 406 (1972).CrossRefGoogle Scholar
  143. 142.
    Muir, C. S., Nasopharyngeal carcinoma in non-Chinese populations with special reference to South East Asia and Africa,Int. J. Cancer 8: 351 – 363 (1971).Google Scholar
  144. 143.
    Muir, C. S., Nasopharyngeal carcinoma in non–Chinese populations, in:Oncogenesis and Herpesviruses(P. M. Biggs, G. de-Thé, and L. N. Payne, eds.), pp. 367–371, IARC Scientific Publication No. 2, IARC, Lyon, France, 1972.Google Scholar
  145. 144.
    Muir, C. S., Geographical differences in cancer patterns, in:Host Environment Interactions in the Etiology of Cancer in Men (R. Doll and I. Vodopija, eds.), pp. 1–13, IARC Scientific Publication No. 7, IARC, Lyon, France, 1973.Google Scholar
  146. 145.
    Muir, C. S., and Oakley, W. F., Nasopharyngeal carcinoma in Sarawak (Borneo),J. Laryngol. 81: 197 – 207 (1967).Google Scholar
  147. 146.
    Muir, C. S., and Shanmugaratnam, K., The incidence of nasopharyngeal cancer in Singapore, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 47–53, UICC Monograph Series, No. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  148. 147.
    Nevo, S., Meyer, W., and Altman, M., Carcinoma of nasopharynx in twins,Cancer 28: 807 – 809 (1971).CrossRefGoogle Scholar
  149. 148.
    Niederman, J. C., and Evans, A. S., Infectious mononucleosis, in:Serological Epidemiology, pp. 119 – 132, Academic Press, New York, 1973.Google Scholar
  150. 149.
    Nielsen, N. H., Mikkelsen, F., and Hart-Hansen, J. P., Nasopharyngeal cancer in Greenland: Incidence in an arctic Eskimo population,Acta Pathol. Mecrobiol. Scand. [A] 85: 850 – 858 (1977).Google Scholar
  151. 150.
    Nilsson, K., Klein, G., Henle, G., and Henle, W., The role of EBV in the establishment of lymphoblastoid cell lines from adult and foetal lymphoid tissue, in:Oncogenesis and Herpesviruses(P. M. Biggs, G. de-Thé, and L. N. Payne, eds.), pp. 285–290, IARC Scientific Publication No. 2, IARC, Lyon, France, 1972.Google Scholar
  152. 151.
    Nonoyama, M., and Pagano, J. S., Homology between Epstein—Barr viruses DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics,Nature 242: 44 – 47 (1973).CrossRefGoogle Scholar
  153. 152.
    O’Conor, G. T., Persistent immunological stimulation as a factor in oncogenesis with special reference to Burkitt’s tumour,Am. J. Med. 48: 279 – 285 (1970).CrossRefGoogle Scholar
  154. 153.
    Old, L. J., Boyse, E. A., Oettgen, H. F., deHarven, E., Geering, G., Williamson, E., and Clifford, P., Precipitation antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells,Proc. Natl. Acad. Sci. U.S.A. 56: 1699 – 1704 (1966).CrossRefGoogle Scholar
  155. 154.
    Pagano, J. S., Huang, C. H., Klein, G., de-Thé, G., Shanmugaratnam, K., Simons, M. J., and Yan, C. S., Homology of Epstein—Barr viral DNA in nasopharyngeal carcinoma from Kenya, Taiwan, Singapore and Tunis, in:Oncogenesis and Herpesviruses II(G. de-Thé, M. A. Epstein, and H. zur Hausen, eds.), pp. 191–193, IARC Scientific Publication No. 11, Vol. 2, IARC, Lyon, France, 1975.Google Scholar
  156. 155.
    Pagano, J. S., Huang, C. H., and Levine, P., Absence of Epstein—Barr viral DNA in American Burkitt’s lymphoma,N. Engl. J. Med. 289: 1395 – 1399 (1973).CrossRefGoogle Scholar
  157. 156.
    Pearson, G. R., Coates, H. L., Needl, H. B., Levine, P., Ablashi, D., and Easton, J., Clinical evaluation of EBV serology in American patients with nasopharyngeal carcinoma, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 439–448, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  158. 157.
    Pearson, G. R., and Orr, T. W., Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein—Barr virus antigens,J. Nat. Cancer Inst. 56: 485 – 488 (1976).Google Scholar
  159. 158.
    Pereira, M. S., Filld, A. M., Blake, J. M., Rodgers, F. G., and Bailey, L. A., Evidence for oral excretion of EB virus in infectious mononucleosis,Lancet 1: 710 – 711 (1972).CrossRefGoogle Scholar
  160. 159.
    Peto, R., Epidemiology, multistage models, and short-term mutagenicity tests, in:Origins of Human Cancer(H. Hiati, J. D. Watson, and J. A. Winsten, eds.), pp. 1403–1428,Cold Spring Harbor Conferences on Cell Proliferation, Vol. Book C, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1977.Google Scholar
  161. 160.
    Poirier, S., Ohshima, H., de-Thé, G., Hubert, A., Bourgade, M. C., and Bartsch, H., Volatile nitrosamine levels in common foods from Tunisia, South China and Greenland, high-risk areas for nasopharyngeal carcinoma (NPC),Int. J. Cancer 39: 293 – 296 (1987).CrossRefGoogle Scholar
  162. 161.
    Polunin, I., The ways of life of people with high rates of nasopharyngeal carcinoma, in:Cancer of the Nasopharynx(C.Muir and K. Shanmugaratnam, eds.), pp. 106–111, IUCC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  163. 162.
    Reedman, B. M., and Klein, G., Cellular localization of an Epstein—Barr virus (EBV) associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines,Int. J. Cancer 11: 499 – 520 (1973).CrossRefGoogle Scholar
  164. 163.
    Reedman, B. M., Klein, G., Pope, J. H., Walters, M. K., Hilgers, J., Smith, S., and Johansson, B., Epstein—Barr virus associated complement fixing and nuclear antigens in Burkitt’s lymphoma biopsies,Int. J. Cancer 13: 755 – 763 (1974).CrossRefGoogle Scholar
  165. 164.
    Reedman, B. M., Pope, J. H., and Moss, D. J., Identity of the soluble EBV associated antigens of human lymphoid cell lines,Int. J. Cancer 9: 172 – 181 (1972).CrossRefGoogle Scholar
  166. 165.
    Saad, A., Observations on nasopharyngeal carcinoma in the Sudan, in:Cancer in Africa(C. A. Linsell and G. L. Limms, eds.), pp. 281–285, East African Publishing House, Nairobi, 1968.Google Scholar
  167. 166.
    Schmauz, R., and Templeton, A. C., Nasopharyngeal cancer in Uganda, Cancer29: 610 – 621 (1972).CrossRefGoogle Scholar
  168. 167.
    Scott, G. C., and Atkinson, L., Demographic features of the Chinese population in Australia and the relative prevalence of nasopharyngeal cancer among Caucasians and Chinese, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 64–72, UICC Monograph Series, Vol. I, Munksgaard, Copenhagen, 1967.Google Scholar
  169. 168.
    Shanmugaratnam, K., Nasopharyngeal carcinoma in Asia, in:Racial and Geographical Factors in Tumour Incidence(A. A. Shivas, ed.), pp. 169–188, Pfizer Medical Monograph, Vol. 2, Edinburgh University Press, Edinburgh, 1967.Google Scholar
  170. 169.
    Shanmugaratnam, K., Studies on the etiology of nasopharyngeal carcinoma,Int. Rev. Exp. Pathol. 10: 361 – 413 (1971).Google Scholar
  171. 170.
    Shanmugaratnam, K., Cancer in Singapore—Ethnic and dialect group variations in cancer incidence,Singapore Med. J. 14: 68 – 81 (1973).Google Scholar
  172. 171.
    Shanmugaratnam, K., and Higginson, J., Aetiology of nasopharyngeal carcinoma: Report on a retrospective survey in Singapore, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 130–137, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  173. 172.
    Shanmugaratnam, K., and Muir, C. S., Nasopharyngeal carcinoma: Origin and structure, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 153–162, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  174. 173.
    Shanmugaratnam, K., and Tye, C. Y., A study of nasopharyngeal cancer among Singapore Chinese with special reference to migrant status and specific community (dialect group),J. Chron. Dis. 23: 433 – 441 (1970).CrossRefGoogle Scholar
  175. 174.
    Shanmugaratnam, K., Tye, C. Y., Goh, E. H., and Chia, K. B., Etiological factors in nasopharyngeal carcinoma: A hospital-based, retrospective case-control questionnaire study, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 199–212, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  176. 175.
    Shanmugaratnam, K., and Wee, A., “Dialect group” variations in cancer incidence among Chinese in Singapore, in:Host Environment Interaction in the Etiology of Cancer in Humans(R. Doll and I. Bodopija, eds.), pp. 67–82, IARC Scientific Publication No. 7, IARC, Lyon, France, 1973.Google Scholar
  177. 176.
    Simons, M. J., Chan, S. H., Wee, G. B., Shanmugaratnam, K., Goh, E. H., Ho, J. L. C., Chau, J. C. W., Darmalingam, S., Prasad, U., Betuel, H., Day, N. E., and de-Thé, G., Nasopharyngeal carcinoma and histocompatibility antigens, in:Nasopharyngeal Carcinoma: Etiology and Control(G. de-Thé and Y. Ito, eds.), pp. 271–282, IARC Scientific Publication No. 20, IARC, Lyon, France, 1978.Google Scholar
  178. 177.
    Simons, M. J., Day, N. E., Wee, G. B., Chan, S. H., Shanmugaratnam, K., and de-Thé, G., Immunogenetic aspects of nasopharyngeal carcinoma (NPC). III. HL-A type as a genetic marker of NPC predisposition to test the hypothesis that EBV is an aetiologic factor in NPC, in:Oncogenesis and Herpesviruses II(G. de-Thé, M. A. Epstein, and H. zur Hausen, eds.), pp. 249–258, IARC Scientific Publication No. 11, Vol. 2, IARC, Lyon, France, 1975.Google Scholar
  179. 178.
    Simons, M. J., Day, N. E., Wee, G. B., Shanmugaratnam, K., Ho, H. C., Wong, S. H., Ti, T. K., Yong, N. K., Darmalingam, S., and de-Thé, G., Nasopharyngeal carcinoma. V. Immunogenetic studies of South East Asian ethnic groups with high and low risk for the tumor,Cancer Res 34: 1192 – 1195 (1974).Google Scholar
  180. 179.
    Simons, M. J., Wee, G. B., Day, N. E., Chan, S. H., Shanmugaratnam, K., and de-Thé, G., Immunogenetic aspects of nasopharyngeal carcinoma (NPC). IV. Probable identification of an HL–A second antigen associated with a high risk for NPC,Lancet 1: 142 – 143 (1975).CrossRefGoogle Scholar
  181. 180.
    Simons, M. J., Wee, G. B., Day, N. E., de-Thé, G., Morris, P. J., and Shanmugaratnam, K., Immunogenetic aspects of nasopharyngeal carcinoma. I. Differences in HL-A antigen profiles between patients and comparison groups,Int. J. Cancer 13: 122 – 134 (1974).CrossRefGoogle Scholar
  182. 181.
    Simons, M. J., Wee, G. B., Goh, E. H., Chan, S. H., Shanmugaratnam, K., Day, N. E., and de-Th–, G., Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2),J. Natl. Cancer Inst. 57:977–980 (1976).Google Scholar
  183. 182.
    Smith, G. E., and Dawson, W. R.,Egyptian Mummies, p. 157, Allen and Unwin, London, 1924.Google Scholar
  184. 183.
    Sohier, R., and de-Thé, G., Fixation du complement avec un antigene soluble: Differences d’activite importantes entre les serums de lymphoma de Burkitt, de cancer du rhinopharynx et de mononucleose infectieuse,C. R. Acad. Sci. [D] (Paris) 273: 121 – 124 (1971).Google Scholar
  185. 184.
    Sohier, R., and de-Thé, G., Evolution of complement-fixing antibody titers with the development of Burkitt’s lymphoma,Int. J. Cancer 9: 524 – 528 (1972).CrossRefGoogle Scholar
  186. 185.
    Svoboda, D. J., Kirchner, K. R., and Shanmugaratnam, K., Ultrastructure of nasopharyngeal carcinomas in American and Chinese patients: An application of electron microscopy to geographic pathology,Exp. Mol. Pathol. 4: 189 – 204 (1965).CrossRefGoogle Scholar
  187. 186.
    Svoboda, D. J., Kirchner, K. R., and Shanmugaratnam, K., The fine structure of nasopharyngeal carcinoma, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 163–171, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  188. 187.
    Terracini, B., Magee, P. N., and Barnes, J. M., Hepatic pathology on low dietary levels of dimethylnitrosamine,Br. J. Cancer 21: 599 – 565 (1967).CrossRefGoogle Scholar
  189. 188.
    Trumper, P. A., Epstein, M. A., Giovanella, G. C., and Finerty, S., Isolation of infectious EB virus from epithelial tumor cells of nasopharyngeal carcinoma,Int. J. Cancer 20: 655 – 662 (1977).CrossRefGoogle Scholar
  190. 189.
    Union International Contre le Cancer,Cancer Incidence in Five Continents—Technical Report(R. Doll, P. Payne, and J. Waterhouse, eds.), UICC, Geneva, 1966.Google Scholar
  191. 190.
    Union International Contre le Cancer, Cancer Incidence in Five Continents, Vol. 2 (R. Doll, C. Muir, and J. Waterhouse, eds.), UICC, Geneva, 1970.Google Scholar
  192. 191.
    Vonka, V., Benyesh-Melnick, M., Lewis, R. T., and Wimberly, I., Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines,Arch. Ges. Virusforsch. 31: 113 – 124 (1970).CrossRefGoogle Scholar
  193. 192.
    Vonka, V., Vlchova, I., Zavadova, H., Kouba, K., Lasovska, J., and Duben, J., Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cell in infectious mononucleosis patients,Int. J. Cancer 9: 529 – 535 (1972).CrossRefGoogle Scholar
  194. 193.
    Vuillaume, M., and de-Thé, G., Nasopharyngeal carcinoma. III. Ultrastructure of different growths leading to lymphoblastoid transformationin vitro, J. Natl. Cancer Inst 51: 67 – 80 (1973).Google Scholar
  195. 194.
    Walshe, R. J., The physical anthropology of races with a high incidence of nasopharyngeal cancer, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 112–118, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  196. 195.
    Walters, M. K., and Pope, J. H., Studies of the EB virus-related antigens of human leukocyte cell lines,Int. J. Cancer 8: 32 – 40 (1971).CrossRefGoogle Scholar
  197. 196.
    Wara, W. M., Wara, D. W., Phillips, T. L., and Ammahh, A., Elevated IgA in carcinoma of the nasopharynx,Cancer 35: 1313 – 1315 (1975).CrossRefGoogle Scholar
  198. 197.
    Wells, C., Ancient Egyptian pathology,J. Laryngol. 77: 261 – 265 (1963).Google Scholar
  199. 198.
    Wells, C., Two mediaeval cases of malignant disease,Br. Med. J. 1:1611–1612 (1964).Google Scholar
  200. 199.
    Williams, E. H., Day, N. E., and Geser, A., Seasonal variation in onset of Burkitt’s lymphoma in the West Nile district of Uganda,Lancet 2: 19 – 22 (1974).CrossRefGoogle Scholar
  201. 200.
    Williams, E. H., and de-Thé, G., Familial aggregation in nasopharyngeal carcinoma (letter to the editor),Lancet 2: 295 (1974).CrossRefGoogle Scholar
  202. 201.
    Wolf, H., zur Hausen, H., and Becker, V., EB viral genomes in epithelial nasopharyngeal carcinoma cells,Nature (New Biol.) 244: 245 – 257 (1973).Google Scholar
  203. 202.
    World Health Organization,Mortality from Malignant Neoplasms 1955–1965, WHO, Geneva, 1970.Google Scholar
  204. 203.
    World Health Organization (WHO),Histological Typing of Upper Respiratory Tract Tumours: International Classification of Tumours, No. 19 ( K. Shanmugaratnam and L. H. Sobin, eds.), WHO, Geneva, 1978.Google Scholar
  205. 204.
    Worth, R. M., and Valentine, R., Nasopharyngeal carcinoma in New South Wales, Australia, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 73–76, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  206. 205.
    Wu, C. H. (ed.),The Encyclopaedia of Chinese Medical Terms, Vol. 1, p. 756, Commercial Press, Shanghai, 1921 (in Chinese).Google Scholar
  207. 206.
    Yata, J., Desgranges, C., de-Thé, G., and Tachibana, T., Lymphocytes in infectious mononucleosis: Properties of atypical cells and origin of the lymphoblastoid lines,Biomedicine 19: 479 – 483 (1973).Google Scholar
  208. 207.
    Yata, J., Desgranges, C., de-Thé, G., and Tachibana, T., Nasopharyngeal carcinoma. VII. Lymphocyte subpopulations in the blood and tumour tissue,Biomedicine 21: 244 – 250 (1974).Google Scholar
  209. 208.
    Yata, J., Desgranges, C., Nakagawa, T., Favri, M. C., and de-Thé, G., Lymphoblastoid transformation and kinetics in the appearance of Epstein—Barr viral nuclear antigen (EBNA) in cord blood B cells by Epstein—Barr virus infection,Int. J. Cancer 15: 377 – 384 (1975).CrossRefGoogle Scholar
  210. 209.
    Yeh, S., Histology of nasopharyngeal cancer, in:Cancer of the Nasopharynx(C. S. Muir and K. Shanmugaratnam, eds.), pp. 147–152, UICC Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  211. 210.
    Young, D., Sixbey, J. W., Clarck, D., and Rickinson, A. B., Epstein—Barr virus receptors on human pharyngeal epithelia,Lancet 1: 240 – 242 (1986).CrossRefGoogle Scholar
  212. 211.
    Yu, M. C., Ho, J. H. C., Lai, S. H., and Henderson, B. E., Cantonese style salted fish as a cause of nasopharyngeal carcinoma: Report of a case-control study in Hong Kong,Cancer Res 46: 956 – 961 (1986).Google Scholar
  213. 212.
    Yun, I. S., A statistical study of tumours among Koreans,Cancer Res 9: 370 – 371 (1949).Google Scholar
  214. 213.
    Zaouche, A.,Les tumeurs malignes de la sphere ORL en Tunisie: A propos des 644 tumeurs des voies aerodigestives superieures a I’lnstitut National de Carcinologie de Tunis due 1.10.67 au 15.8.69, Thesis, Paris, 1970.Google Scholar
  215. 214.
    Zeng, Y., Seroloepidemiological studies of nasopharyngeal carcinoma in China,Adv. Cancer Res. 44: 121 – 138, (1985).CrossRefGoogle Scholar
  216. 215.
    Zeng, Y., Gong, C. H., Jan, M. G., Fun, Z., Zhang, L. G., and Li, H. Y., Detection of Epstein—Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography,Int. J. Cancer 31: 599 – 601 (1983).CrossRefGoogle Scholar
  217. 216.
    Zeng, Y., Liu, Y. X., Liu, C. R., Chen, S. W., Wei, J. N., Zhu, J. N., and Zai, H. J., Application of immunoenzymatic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma,Intervirology 133: 166 – 168 (1980).Google Scholar
  218. 217.
    Zeng, Y., Shang, M., Liu, C. R., Chen, S. W., Wei, J. N., Zhu, J. S., and Zai, H. G., Detection of anti Epstein—Barr virus IgA in NPC patients in 8 provinces and cities in China,Chinese Oncology 1: 2 – 7 (1979).Google Scholar
  219. 218.
    Zeng, Y., Shen, S., Pi, G., Ma, J. L., Zhang, Q., Zhao, M. G., and Dong, H. J., Application of anticomplement immunoenzymatic method for the detection of EBNA in carcinoma cells and normal epithelial cells from the nasopharynx, in:Nasopharyngeal Carcinoma, Cancer Campaign, Vol. 5, ( E. Gzundman, G. Kzueger, E. Zundman, G. R. F. Kzueger, and D. B. Ablashi, eds.), Gustav Fischer Verlag, Stuttgart, 1981.Google Scholar
  220. 219.
    Zeng, Y., Zhang, L. G., Li, H. Y.,Jan, M. G.,Zhang, Q., Wu, Y. C., Wang, Y. S., and Su, G. R., Serological mass survey for early detection of nasopharyngeal carcinoma in Wu-Zhou City, China,Int. J. Cancer 29: 139 – 141 (1982).CrossRefGoogle Scholar
  221. 220.
    Zeng, Y., Zhong, J. M., Li, L. Y., Wang, P. Z., Tang, H., Ma, Y. R., Zhu, J. S., Pan, W. J., Lio, Y. X., Wei, Z. N., Chen, J. Y., Mo, Y. K., Li, E. J., and Tan, B. F., Follow-up studies on Epstein—Barr virus IgA/VCA antibody positive persons in Zangwu County, China,Intervirology 20: 190 – 194 (1983).CrossRefGoogle Scholar
  222. 221.
    zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Santesson, L., EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx,Nature 228: 1056 – 1058 (1970).CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • G. de Thé
    • 1
  • J. H. C. Ho
    • 2
  • C. S. Muir
    • 3
  1. 1.CNRS LaboratoriesFaculty of Medicine A. CarrelLyonFrance
  2. 2.Institute of Radiology and OncologyQueen Elizabeth Hospital and Baptist HospitalKowloonHong Kong
  3. 3.International Agency for Research on CancerLyonFrance

Personalised recommendations